Serious Injuries Linked to Zantac®

Based on results of Lab testing, the Food and Drug Administration has determined that Zantac® and other ranitidine based medicines have a nitrosamine issue named N–nitrosodimethylamine (NDMA) at lower concentrations. NDMA is known as a probable human carcinogen – a substance might cause cancer in humans. NDMA is a known environmental contaminant and observed in water supplies and food sources, including meat, dairy items, and vegetables.


What is NDMA?

N–nitrosodimethylamine (NDMA) is considered as a probable human carcinogen that means that it’s more probable than not to cause cancer in humans. NDMA has been researched in animal populations and observed to increase the creation of cancer in the animals. The studies have enhanced the chance of an association between NDMA and liver toxicity that may lead to the development of liver cancer and various related conditions brought about by an NDMA–induced treatment of the liver.


The amount and length of human NDMA exposure which may begin the development of cancer is not exactly known. Similarly, the extent and duration of the NDMA contamination of Zantac® and various ranitidine medications are not precisely known.


Diseases Connected with Exposure to NDMA

NDMA has been studied in animal populations and determined to increase the occurrence of cancer in the animals. In light of these studies, the Environmental Protection Agency classifies NDMA as a likely human carcinogen. The studies have increased the likeliness of a connection between NDMA and liver toxicity which can lead to the creation of liver cancer and other related issues due to an NDMA injury to the liver. Others have suggested that NDMA could also be linked to other cancers such as:


Stomach Cancer, Colorectal Cancer, Prostate Cancer, Non–Hodgkin’s Lymphoma.


Has Other Ranitidine Products Been Affected?

Yes. The U.S. Food and Drug Administration has alerted health care professionals and patients to three existing voluntary recalls of ranitidine.


Perrigo Company plc has voluntarily recalled over–the–counter (OTC) ranitidine tablets because of the possibility of N–Nitrosodimethylamine (NDMA) in the medication.

Novitium Pharma LLC has voluntarily recalled all unexpired quantities and lots of ranitidine hydrochloride medication because of the possibility of NDMA in the medication.

Lannett Company, Inc. has voluntarily recalled all unexpired lots of prescription ranitidine syrup due to the presence of NDMA found in the drug.

Should I Cease Taking Zantac® or Other Ranitidine Medicines?

As of October 28, 2019, the FDA advised patients and consumers taking Zantac® and other ranitidine medicines as follows:


“Patients taking prescription ranitidine who wish to stop should talk to their health care professional about other treatment options. Consumers taking OTC ranitidine, which is used to prevent and relieve heartburn associated with acid indigestion and sour stomach, may consider using other OTC products approved for their condition. FDA’s testing of samples of alternatives such as Pepcid (famotidine), Tagamet (cimetidine), Nexium (esomeprazole), Prevacid (lansoprazole), and Prilosec (omeprazole) show no NDMA in these medicines.”

zantac lawsuit is a leading consumer advocate for the recovery of damages due to NDMA exposure. Feel free to reach out at any time to explore your injury and potential for recovery.